These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3743408)

  • 1. Fenetylline: therapeutic use, misuse and/or abuse.
    Kristen G; Schaefer A; von Schlichtegroll A
    Drug Alcohol Depend; 1986 Jun; 17(2-3):259-71. PubMed ID: 3743408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO.
    Keup W
    Drug Alcohol Depend; 1986 Jun; 17(2-3):169-92. PubMed ID: 2874968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of attention deficit disorders in adulthood using psychostimulants and low-dose neuroleptics--a critical case report].
    Schmidt LG; Schlünder M; Reischies FM
    Psychiatr Prax; 1988 Mar; 15(2):62-5. PubMed ID: 2898788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential adverse effects of amphetamine treatment on brain and behavior: a review.
    Berman SM; Kuczenski R; McCracken JT; London ED
    Mol Psychiatry; 2009 Feb; 14(2):123-42. PubMed ID: 18698321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenethylline (Captagon) Abuse - Local Problems from an Old Drug Become Universal.
    Katselou M; Papoutsis I; Nikolaou P; Qammaz S; Spiliopoulou C; Athanaselis S
    Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):133-40. PubMed ID: 27004621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mefenorex (Rondimen).
    Engel J; Kristen G; Schaefer A; von Schlichtegroll A
    Drug Alcohol Depend; 1986 Jun; 17(2-3):229-34. PubMed ID: 3743406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenetylline: new results on pharmacology, metabolism and kinetics.
    Nickel B; Niebch G; Peter G; von Schlichtegroll A; Tibes U
    Drug Alcohol Depend; 1986 Jun; 17(2-3):235-57. PubMed ID: 3743407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of minimal brain dysfunction syndrome (clinical study using Captagon)].
    Mangold B
    Prax Kinderpsychol Kinderpsychiatr; 1975 Jul; 24(5):185-90. PubMed ID: 1187555
    [No Abstract]   [Full Text] [Related]  

  • 10. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captagon: use and trade in the Middle East.
    Al-Imam A; Santacroce R; Roman-Urrestarazu A; Chilcott R; Bersani G; Martinotti G; Corazza O
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 27766667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmedical use of prescription stimulants in the United States.
    Kroutil LA; Van Brunt DL; Herman-Stahl MA; Heller DC; Bray RM; Penne MA
    Drug Alcohol Depend; 2006 Sep; 84(2):135-43. PubMed ID: 16480836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nonmedical use of prescription stimulants among dental and dental hygiene students.
    McNiel AD; Muzzin KB; DeWald JP; McCann AL; Schneiderman ED; Scofield J; Campbell PR
    J Dent Educ; 2011 Mar; 75(3):365-76. PubMed ID: 21368261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.
    Poulin C
    Addiction; 2007 May; 102(5):740-51. PubMed ID: 17506151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine-induced chorea in attention deficit-hyperactivity disorder.
    Morgan JC; Winter WC; Wooten GF
    Mov Disord; 2004 Jul; 19(7):840-842. PubMed ID: 15254949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental psychophysiological studies on the effects of fenetylline and mefenorex].
    Netter P; Janke W; Vetter J; Schultz-Vetter S
    Arzneimittelforschung; 1978; 28(8):1310-2. PubMed ID: 37853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
    Kollins SH
    J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS
    Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.